Oxidative status in different settings and with different methodological approaches compared by Receiver Operating Characteristic curve analysis

Giuliana Cighetti, Fabrizia Bamonti, Caroline S. Aman, Dario Gregori, Rachele De Giuseppe, Cristina Novembrino, Federica de Liso, Rita Maiavacca, Rita Paroni

Research output: Contribution to journalArticle

Abstract

Objectives: To test the performance of different analytical approaches in highlighting the occurrence of deregulated redox status in various physio-pathological situations. Design and methods: 35 light and 61 heavy smokers, 19 chronic renal failure, 59 kidney transplanted patients, and 87 healthy controls were retrospectively considered for the study.Serum oxidative stress and antioxidant status, assessed by spectrophotometric Reactive Oxygen Metabolites (d-ROMs) and Total Antioxidant Capacity (TAC) tests, respectively, were compared with plasma free (F-MDA) and total (T-MDA) malondialdehyde, both quantified by isotope-dilution-gas chromatography-mass spectrometry (ID-GC-MS). Sensitivity, specificity and cut-off points of T-MDA, F-MDA, d-ROMs and TAC were evaluated by both Receiver Operating Characteristic (ROC) analyses and area under the ROC curve (AUC). Results: Only T-MDA assay showed a clear absence of oxidative stress in controls and significant increase in all patients (AUC 1.00, sensitivity and specificity 100%). Accuracy was good for d-ROMs (AUC 0.87, sensitivity 72.8%, specificity 100%) and F-MDA (AUC 0.82, sensitivity 74.7%, specificity 83.9%), but not high enough for TAC to show in patients impaired antioxidant defense (AUC 0.66, sensitivity 52.0%, specificity 92.9%). Conclusions: This study reveals T-MDA as the best marker to detect oxidative stress, shows the ability of d-ROMs to identify modified oxidative status particularly in the presence of high damages, and evidences the poor TAC performance. d-ROMs and TAC assays could be useful for routine purposes; however, for an accurate clinical data evaluation, their comparison versus a "gold standard method" is required.

Original languageEnglish
Pages (from-to)73-78
Number of pages6
JournalClinical Biochemistry
Volume48
Issue number1-2
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

ROC Curve
ROM
Antioxidants
Area Under Curve
Oxidative stress
Sensitivity and Specificity
Oxidative Stress
Assays
Metabolites
Malondialdehyde
Isotopes
Gas chromatography
Gas Chromatography-Mass Spectrometry
Dilution
Chronic Kidney Failure
Oxidation-Reduction
Mass spectrometry
Oxygen
Kidney
Plasmas

Keywords

  • Antioxidant status
  • Isotope-dilution-gas chromatography-mass spectrometry
  • Malondialdehyde
  • Method comparison
  • Oxidative stress
  • ROC curve analysis

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Medicine(all)

Cite this

Oxidative status in different settings and with different methodological approaches compared by Receiver Operating Characteristic curve analysis. / Cighetti, Giuliana; Bamonti, Fabrizia; Aman, Caroline S.; Gregori, Dario; De Giuseppe, Rachele; Novembrino, Cristina; de Liso, Federica; Maiavacca, Rita; Paroni, Rita.

In: Clinical Biochemistry, Vol. 48, No. 1-2, 01.01.2015, p. 73-78.

Research output: Contribution to journalArticle

Cighetti, Giuliana ; Bamonti, Fabrizia ; Aman, Caroline S. ; Gregori, Dario ; De Giuseppe, Rachele ; Novembrino, Cristina ; de Liso, Federica ; Maiavacca, Rita ; Paroni, Rita. / Oxidative status in different settings and with different methodological approaches compared by Receiver Operating Characteristic curve analysis. In: Clinical Biochemistry. 2015 ; Vol. 48, No. 1-2. pp. 73-78.
@article{676dd6ec468d4a75aeca6ca8acf9ff68,
title = "Oxidative status in different settings and with different methodological approaches compared by Receiver Operating Characteristic curve analysis",
abstract = "Objectives: To test the performance of different analytical approaches in highlighting the occurrence of deregulated redox status in various physio-pathological situations. Design and methods: 35 light and 61 heavy smokers, 19 chronic renal failure, 59 kidney transplanted patients, and 87 healthy controls were retrospectively considered for the study.Serum oxidative stress and antioxidant status, assessed by spectrophotometric Reactive Oxygen Metabolites (d-ROMs) and Total Antioxidant Capacity (TAC) tests, respectively, were compared with plasma free (F-MDA) and total (T-MDA) malondialdehyde, both quantified by isotope-dilution-gas chromatography-mass spectrometry (ID-GC-MS). Sensitivity, specificity and cut-off points of T-MDA, F-MDA, d-ROMs and TAC were evaluated by both Receiver Operating Characteristic (ROC) analyses and area under the ROC curve (AUC). Results: Only T-MDA assay showed a clear absence of oxidative stress in controls and significant increase in all patients (AUC 1.00, sensitivity and specificity 100{\%}). Accuracy was good for d-ROMs (AUC 0.87, sensitivity 72.8{\%}, specificity 100{\%}) and F-MDA (AUC 0.82, sensitivity 74.7{\%}, specificity 83.9{\%}), but not high enough for TAC to show in patients impaired antioxidant defense (AUC 0.66, sensitivity 52.0{\%}, specificity 92.9{\%}). Conclusions: This study reveals T-MDA as the best marker to detect oxidative stress, shows the ability of d-ROMs to identify modified oxidative status particularly in the presence of high damages, and evidences the poor TAC performance. d-ROMs and TAC assays could be useful for routine purposes; however, for an accurate clinical data evaluation, their comparison versus a {"}gold standard method{"} is required.",
keywords = "Antioxidant status, Isotope-dilution-gas chromatography-mass spectrometry, Malondialdehyde, Method comparison, Oxidative stress, ROC curve analysis",
author = "Giuliana Cighetti and Fabrizia Bamonti and Aman, {Caroline S.} and Dario Gregori and {De Giuseppe}, Rachele and Cristina Novembrino and {de Liso}, Federica and Rita Maiavacca and Rita Paroni",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.clinbiochem.2014.09.025",
language = "English",
volume = "48",
pages = "73--78",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "1-2",

}

TY - JOUR

T1 - Oxidative status in different settings and with different methodological approaches compared by Receiver Operating Characteristic curve analysis

AU - Cighetti, Giuliana

AU - Bamonti, Fabrizia

AU - Aman, Caroline S.

AU - Gregori, Dario

AU - De Giuseppe, Rachele

AU - Novembrino, Cristina

AU - de Liso, Federica

AU - Maiavacca, Rita

AU - Paroni, Rita

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objectives: To test the performance of different analytical approaches in highlighting the occurrence of deregulated redox status in various physio-pathological situations. Design and methods: 35 light and 61 heavy smokers, 19 chronic renal failure, 59 kidney transplanted patients, and 87 healthy controls were retrospectively considered for the study.Serum oxidative stress and antioxidant status, assessed by spectrophotometric Reactive Oxygen Metabolites (d-ROMs) and Total Antioxidant Capacity (TAC) tests, respectively, were compared with plasma free (F-MDA) and total (T-MDA) malondialdehyde, both quantified by isotope-dilution-gas chromatography-mass spectrometry (ID-GC-MS). Sensitivity, specificity and cut-off points of T-MDA, F-MDA, d-ROMs and TAC were evaluated by both Receiver Operating Characteristic (ROC) analyses and area under the ROC curve (AUC). Results: Only T-MDA assay showed a clear absence of oxidative stress in controls and significant increase in all patients (AUC 1.00, sensitivity and specificity 100%). Accuracy was good for d-ROMs (AUC 0.87, sensitivity 72.8%, specificity 100%) and F-MDA (AUC 0.82, sensitivity 74.7%, specificity 83.9%), but not high enough for TAC to show in patients impaired antioxidant defense (AUC 0.66, sensitivity 52.0%, specificity 92.9%). Conclusions: This study reveals T-MDA as the best marker to detect oxidative stress, shows the ability of d-ROMs to identify modified oxidative status particularly in the presence of high damages, and evidences the poor TAC performance. d-ROMs and TAC assays could be useful for routine purposes; however, for an accurate clinical data evaluation, their comparison versus a "gold standard method" is required.

AB - Objectives: To test the performance of different analytical approaches in highlighting the occurrence of deregulated redox status in various physio-pathological situations. Design and methods: 35 light and 61 heavy smokers, 19 chronic renal failure, 59 kidney transplanted patients, and 87 healthy controls were retrospectively considered for the study.Serum oxidative stress and antioxidant status, assessed by spectrophotometric Reactive Oxygen Metabolites (d-ROMs) and Total Antioxidant Capacity (TAC) tests, respectively, were compared with plasma free (F-MDA) and total (T-MDA) malondialdehyde, both quantified by isotope-dilution-gas chromatography-mass spectrometry (ID-GC-MS). Sensitivity, specificity and cut-off points of T-MDA, F-MDA, d-ROMs and TAC were evaluated by both Receiver Operating Characteristic (ROC) analyses and area under the ROC curve (AUC). Results: Only T-MDA assay showed a clear absence of oxidative stress in controls and significant increase in all patients (AUC 1.00, sensitivity and specificity 100%). Accuracy was good for d-ROMs (AUC 0.87, sensitivity 72.8%, specificity 100%) and F-MDA (AUC 0.82, sensitivity 74.7%, specificity 83.9%), but not high enough for TAC to show in patients impaired antioxidant defense (AUC 0.66, sensitivity 52.0%, specificity 92.9%). Conclusions: This study reveals T-MDA as the best marker to detect oxidative stress, shows the ability of d-ROMs to identify modified oxidative status particularly in the presence of high damages, and evidences the poor TAC performance. d-ROMs and TAC assays could be useful for routine purposes; however, for an accurate clinical data evaluation, their comparison versus a "gold standard method" is required.

KW - Antioxidant status

KW - Isotope-dilution-gas chromatography-mass spectrometry

KW - Malondialdehyde

KW - Method comparison

KW - Oxidative stress

KW - ROC curve analysis

UR - http://www.scopus.com/inward/record.url?scp=84920276268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920276268&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2014.09.025

DO - 10.1016/j.clinbiochem.2014.09.025

M3 - Article

C2 - 25305628

AN - SCOPUS:84920276268

VL - 48

SP - 73

EP - 78

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 1-2

ER -